文献速递临床试验与 GCP

围术期叹息通气对体外循环心脏手术后低氧血症和肺部并发症的影响(E-SIGHT):随机对照试验研究方案

Effect of perioperative sigh ventilation on postoperative hypoxemia and pulmonary complications after on-pump cardiac surgery (E-SIGHT): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-09-04

E-SIGHT试验为单中心、双臂随机对照试验,计划纳入192例择期体外循环心脏手术患者,比较常规肺保护性通气基础上加用围术期叹息通气与单纯常规肺保护性通气对术后低氧血症和肺部并发症的影响,主要终点为拔管后最初1小时时间加权平均SpO2/FiO2比值。

要点

  • 试验组在常规肺保护性通气基础上加用叹息通气,平台压35 cmH2O(BMI>35 kg/m2者40 cmH2O),从插管至拔管每6分钟一次。
  • 对照组采用常规肺保护性通气,不进行预先计划的肺复张操作。
  • 主要终点为拔管后最初1小时时间加权平均SpO2/FiO2比值,主要次要终点为术后第7天计算的肺部并发症严重程度。

核心结论

  • E-SIGHT试验将是首个评估围术期叹息通气对体外循环心脏手术后结局影响的随机对照试验。
  • 该试验将引入并评估一种新的围术期通气方法,以降低心脏手术患者术后低氧血症和肺部并发症的风险。
  • 该试验还将为未来更大规模的试验提供基础,以验证叹息通气对术后肺部并发症的影响。

研究设计与样本

  • E-SIGHT试验为单中心、双臂随机对照试验。
  • 计划纳入192例择期体外循环(CPB)并主动脉阻断的心脏手术患者,随机分配至两个治疗组之一。

主要发现

  • 试验组在常规肺保护性通气基础上,从插管至拔管每6分钟给予一次叹息通气,平台压35 cmH2O(体重指数>35 kg/m2者40 cmH2O)。
  • 对照组采用常规肺保护性通气,不进行预先计划的肺复张操作。
  • 肺保护性通气包括低潮气量(预测体重6-8 mL/kg)和根据急性呼吸窘迫综合征(ARDS)低PEEP/FiO2表设置呼气末正压(PEEP)。
  • 主要终点为拔管后最初1小时时间加权平均SpO2/FiO2比值。
  • 主要次要终点为术后第7天计算的术后肺部并发症(PPCs)严重程度。

关键数值与推荐

  • 试验组叹息通气平台压35 cmH2O,体重指数>35 kg/m2者40 cmH2O。
  • 叹息通气频率为从插管至拔管每6分钟一次。
  • 肺保护性通气潮气量为预测体重6-8 mL/kg,PEEP根据ARDS低PEEP/FiO2表设置。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative hypoxemia and pulmonary complications remain a frequent event after on-pump cardiac surgery and mostly characterized by pulmonary atelectasis. Surfactant dysfunction or hyposecretion happens prior to atelectasis formation, and sigh represents the strongest stimulus for surfactant secretion. The role of sigh breaths added to conventional lung protective ventilation in reducing postoperative hypoxemia and pulmonary complications among cardiac surgery is unknown. METHODS: The perioperative sigh ventilation in cardiac surgery (E-SIGHT) trial is a single-center, two-arm, randomized controlled trial. In total, 192 patients scheduled for elective cardiac surgery with cardiopulmonary bypass (CPB) and aortic cross-clamp will be randomized into one of the two treatment arms. In the experimental group, besides conventional lung protective ventilation, sigh volumes producing plateau pressures of 35 cmH2O (or 40 cmH2O for patients with body mass index > 35 kg/m2) delivered once every 6 min from intubation to extubation. In the control group, conventional lung protective ventilation without preplanned recruitment maneuvers is used. Lung protective ventilation (LPV) consists of low tidal volumes (6-8 mL/kg of predicted body weight) and positive end-expiratory pressure (PEEP) setting according to low PEEP/FiO2 table for acute respiratory distress syndrome (ARDS). The primary endpoint is time-weighted average SpO2/FiO2 ratio during the initial post-extubation hour. Main secondary endpoint is the severity of postoperative pulmonary complications (PPCs) computed by postoperative day 7. DISCUSSION: The E-SIGHT trial will be the first randomized controlled trial to evaluate the impact of perioperative sigh ventilation on the postoperative outcomes after on-pump cardiac surgery. The trial will introduce and assess a novel perioperative ventilation approach to mitigate the risk of postoperative hypoxemia and PPCs in patients undergoing cardiac surgery. Also provide the basis for a future larger trial aiming at verifying the impact of sigh ventilation on postoperative pulmonary complications. TRIAL REGISTRATION: ClinicalTrials.gov NCT06248320. Registered on January 30, 2024. Last updated February 26, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang Z, Cheng Q, Huang S, et al. Effect of perioperative sigh ventilation on postoperative hypoxemia and pulmonary complications after on-pump cardiac surgery (E-SIGHT): study protocol for a randomized controlled trial. Trials. 2024. PMID: 39232795. doi:10.1186/s13063-024-08416-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。